Fernando Pitossi -
Fernando Pitossi graduated in biochemistry at the University of Buenos Aires in 1988. Then he moved to the Friedrich Miescher Institute in Basel, Switzerland, where he identified and cloned protein kinase B (Akt). A year later, he started his doctorate in molecular virology on the molecular mechanisms of the antiviral action of interferons at the University of Zurich, Switzerland. He later completed his doctorate at the University of Freiburg, Germany, in 1993. For the next four years, he worked as a research scientist in the Department of Immunophysiology at the University of Marburg, Germany, studying the interactions between the immune system and the central nervous system . During this period, he studied the generation and use of recombinant adenoviral vectors as vehicles for gene transfer in the brain with Prof. Mallet in Paris and gained experience in inflammation research with Daniel Anthony and Hugh Perry in Oxford, UK. In 1997, he returned to Argentina and established himself as an associate researcher before becoming the leader of the Neuroimmunomodulation and Gene Therapy laboratory group at the Leloir Foundation in 2000. His current research interests are focused on the functional role of immune pro-inflammatory cytokines in neurodegeneration, neuroprotection and stem cell biology. Your group is collaborating with Prof. W. Oertel (Neurology Clinic, Marburg, Germany), Dr. U. Eisel (University of Struttgart, Germany), Dr. D. Anthony and H. Perry (University of Southampton, United Kingdom). He serves as an advisor to the Argentine Food and Drug Administration on clinical trials with recombinant DNA and is a member of several study sections at the Society for Neuroscience, International Society for Cytokines, Society for Interferon and Cytokine Research and European Society for Cytokines. Pitossi received several national and international grants from organizations such as the Volkswagen Foundation, Wellcome Trust and Deutsche Akademische Austauschdienst.